Back to top
more

Franklin Strategic Biotechnology Discovery Fund Class A: (MF: FBDIX)

(NASDAQ Mutual Funds) As of Jan 19, 2019 08:15 PM ET

 Add to portfolio

$140.23 USD

+0.82 (0.59%)

Zacks MF Rank 3-Hold     3    

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

View All Zacks Mutual Fund Rank #1's

Latest Performance as of Dec 31, 2018

Total Return %* Percentile Rank Objective
YTD -15.71 97
3 months -22.31 90
6 months -18.45 98
1 Year -15.72 97
3 Year -6.04 98
5 Year 3.22 96
10 Year 13.77 57

* Annual for three years and beyond.

Zacks Premium Research for FBDIX

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Zacks MF Rank Hold 3
MF Research Report

Mutual Funds Research & Tools

Search Similar Mutual Funds

Research similar Mutual Funds with higher ranks and performance ratings.

Mutual Funds Comparison View (minimum of 2)

Mutual Funds Screener

Narrow down the universe of 18,000+ funds we rank with our robust, yet easy-to-use mutual fund screeners. Select from up to 50 different data points to find the mutual funds that best Screen meet your unique criteria.

Portfolio Statistics

%Unrealized Gain YTD 40.70
% Yield 0.00
% SEC Yield
Net Assets (Mil $) 12/31/2018 952.82
%Turnover 12/31/2018 26.95

Risk

3 Year 5 Year 10 Year
Beta 1.65 1.36 0.97
Alpha -16.46 -5.20 2.51
R Squared 0.52 0.36 0.36
Std. Dev. 25.29 24.85 22.15
Sharpe -0.15 0.23 3.00

Sector / Country Weightings

As of 12/31/2018 % of Portfolio
Health 71.78
Other 11.72
Industrial Cyclical 6.06
Services 5.28
Technology 5.16

Portfolio Holdings

Top Equity Holdings
(As of 7/31/2018)
% of Portfolio Value (Mil$)
ALEXION PHARMACEUTICALS I 7.80 110.20
CELGENE CORP 6.94 98.01
BIOGEN IDEC INC 5.80 81.94
VERTEX PHARMACEUTICALS IN 5.51 77.90
ILLUMINA INC 5.16 72.88
NA 5.10 72.05
REGENERON PHARMACEUTICALS 3.75 52.92
GILEAD SCIENCES INC 3.44 48.60
AMGEN INC 3.23 45.66

Stock Holding % of Net Assets

As Of 7/31/2018
Total Issues 96
Avg. P/E 47.51
Avg. P/Book 5.65
Avg. EPS Growth 15.5
Avg. Market Value (Mil $) 29,580

Allocation

% of Portfolio
Large Growth 27.62
Large Value 0.00
Small Growth 46.10
Small Value 0.00
Foreign Stock 0.00
Emerging Market 0.00
Precious Metal 4.36
Intermediate Bond 0.00
Foreign Bond 0.00
High Yield Bond 0.00